These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30059069)

  • 21. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
    J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignancy grading of glial tumors. I. Astrocytomas].
    Martin H; Schmidt D
    Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas.
    Sahm F; Korshunov A; Schrimpf D; Stichel D; Jones DT; Capper D; Koelsche C; Reuss D; Kratz A; Huang K; Wefers AK; Schick M; Bewerunge-Hudler M; Mittelbronn M; Platten M; Hänggi D; Jeibmann A; Unterberg A; Herold-Mende C; Pfister SM; Brandner S; Wick W; von Deimling A
    Acta Neuropathol; 2017 Feb; 133(2):325-327. PubMed ID: 28000032
    [No Abstract]   [Full Text] [Related]  

  • 24. Practical molecular pathologic diagnosis of pilocytic astrocytomas.
    Reis GF; Tihan T
    Surg Pathol Clin; 2015 Mar; 8(1):63-71. PubMed ID: 25783822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.
    Burger PC; Vogel FS; Green SB; Strike TA
    Cancer; 1985 Sep; 56(5):1106-11. PubMed ID: 2990664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular mechanisms targeted during astrocytoma progression.
    Collins VP
    Cancer Lett; 2002 Dec; 188(1-2):1-7. PubMed ID: 12406541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.
    Polisetty RV; Gautam P; Gupta MK; Sharma R; Gowda H; Renu D; Shivakumar BM; Lakshmikantha A; Mariswamappa K; Ankathi P; Purohit AK; Uppin MS; Sundaram C; Sirdeshmukh R
    Sci Rep; 2016 Jun; 6():26882. PubMed ID: 27246909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis.
    Holland H; Koschny T; Ahnert P; Meixensberger J; Koschny R
    Pathol Res Pract; 2010 Oct; 206(10):663-8. PubMed ID: 20570053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
    Brat DJ; Aldape K; Colman H; Figrarella-Branger D; Fuller GN; Giannini C; Holland EC; Jenkins RB; Kleinschmidt-DeMasters B; Komori T; Kros JM; Louis DN; McLean C; Perry A; Reifenberger G; Sarkar C; Stupp R; van den Bent MJ; von Deimling A; Weller M
    Acta Neuropathol; 2020 Mar; 139(3):603-608. PubMed ID: 31996992
    [No Abstract]   [Full Text] [Related]  

  • 36. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2018 Jan; 55(1):402-408. PubMed ID: 27975172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiosurgery for intracranial gliomas.
    Kida Y; Yoshimoto M; Hasegawa T
    Prog Neurol Surg; 2009; 22():122-128. PubMed ID: 18948724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.
    MacDonald TJ; Pollack IF; Okada H; Bhattacharya S; Lyons-Weiler J
    Methods Mol Biol; 2007; 377():203-22. PubMed ID: 17634619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplification of the anonymous marker D17S67 in malignant astrocytomas.
    Bijlsma EK; Leenstra S; Westerveld A; Bosch DA; Hulsebos TJ
    Genes Chromosomes Cancer; 1994 Feb; 9(2):148-52. PubMed ID: 7513547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
    Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
    J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.